Dataset Information

TMEM160 Promotes Tumor Growth in Lung Adenocarcinoma and Cervical Adenocarcinoma Cell Lines

ABSTRACT: This dataset corresponds to the proteomic characterization of the TMEM160 interactome in A549 cells using co-immunoprecipitation (Co-IP) followed by data-independent acquisition mass spectrometry (DIA-MS). TMEM160 was immunoprecipitated using an anti-TMEM160 antibody, and interacting proteins were identified through LC–MS/MS analysis using a Q-Exactive HF-X system. Protein identification and quantification were performed in DIA-NN (v1.8.1) in library-free mode using the UniProt Human reference proteome.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Lung, Permanent Cell Line Cell

DISEASE(S): Lung Adenocarcinoma

SUBMITTER: ANGELINA HERRERA-QUITERIO

LAB HEAD: Sergio Encarnación-Guevara

PROVIDER: PXD071042 | Pride | 2025-12-01

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	20230621_M_CC_10_CoIP--A549-1.raw	Raw
	20230621_M_CC_1_CoIP_A549-3.raw	Raw
	20230621_M_CC_2_CoIP_A549-2.raw	Raw
	20230621_M_CC_3_CoIP_A549-1.raw	Raw
	20230621_M_CC_8_CoIP--A549-3.raw	Raw

Items per page:

1 - 5 of 14

Publications

TMEM160 Promotes Tumor Growth in Lung Adenocarcinoma and Cervical Adenocarcinoma Cell Lines.

Herrera-Quiterio Gloria Angelina GA Valencia-González Heriberto Abraham HA de la Cruz-López Karen Griselda KG Fernández-Coto Diana Lashidua DL Gil Jeovanis J Marko-Varga György G Morales-Gálvez Josué J Sánchez Nilda C NC Rodríguez-Bautista Rubén R Avilés-Salas Alejandro A Arrieta Oscar O García-Carrancá Alejandro A Encarnación-Guevara Sergio S

International journal of molecular sciences 20250127 3

The Chromosome-Centric Human Proteome Project (C-HPP) is an international initiative. It aims to create a protein list expressed in human cells by each chromosomal and mitochondrial DNA to enhance our understanding of disease mechanisms, akin to the gene list generated by the Human Genome Project. Transmembrane protein 160 (TMEM160) is a member of the transmembrane proteins (TMEM) family. TMEM proteins have been implicated in cancer-related processes, including cell proliferation, migration, epi ...[more]

PMID: 39940865

Similar Datasets

Project description:While plasma and serum are increasingly being studied by using high throughput proteomics, it remains largely unexplored how different types of blood materials collected in the routine clinical diagnostics laboratories influence protein marker discovery. We compared the LC-MS/MS proteomic profiles of pooled blood samples from three healthy, voluntary donors in the form of EDTA-, citrate- and heparin-anticoagulated blood as well as serum generated with and without separation gel. Sample preparation was conducted with five different methods. We systematically evaluated the commercially available iST and ENRICH iST kits from Preomics as well as strong-anion exchange (SAX) beads from MagReSyn, the TFA-based approach SPEED and a depletion-based method which uses perchloric acid (perCA) for precipitation of large proteins. Mass-spectrometric measurements were performed on a Q Exactive HF-X and a timsTOF HT in data independent acquisition (DIA) mode. Regarding all possible combinations of sample preparation and matrices, the Q Exactive HF-X MS instrument identified between 250 and 600 protein groups whereas the timsTOF HT identified between 275 and 1100 protein groups. Differences on protein group ID level in the applied sample preparation techniques were evident. Workflows using SAX-beads, ENRICH iST and the perchloric acid precipitation showed highest identification numbers but also highest variability between the different blood matrices. EDTA-plasma and serum exhibited the highest ID numbers while citrated plasma showed the lowest. 116 protein groups overlapped between all 25 sample sets for Q Exactive HF-X and 181 protein groups for timsTOF HT. Importantly, subsets of protein groups were unique for specific combinations of sample preparation and blood matrix. This study shows a systematic approach to determine suitable sample preparation and matrix parameters for the robust identification of individual body fluid marker proteins by mass spectrometry.